J. B. Chemicals & Pharmaceuticals Limited
NSE: JBCHEPHARM BSE: JBCHEPHARM
NSE
1,699.90
-5.60 (-0.33%)
Prev Close
1705.5
Open Price
1706
Volume
56,240
Today Low / High
1694.8 / 1715.5
52 WK Low / High
1385.75 / 1984
Range
1,615 - 1,785
BSE
1,700.10
-6.85 (-0.40%)
Prev Close
1706.95
Open Price
1705.2
Volume
936
Today Low / High
1694.05 / 1709.3
52 WK Low / High
1303 / 1998
Range
1,615 - 1,785
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1699.9 (target range: 1,615 - 1,785), reflecting a change of -5.6 (-0.32835%). On the BSE, it is listed at 1700.1 (target range: 1,615 - 1,785), showing a change of -6.85 (-0.4013%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
12 Sep
1,706.00
-0.36%
11 Sep
1,712.10
-0.39%
10 Sep
1,738.10
-1.63%
09 Sep
1,722.00
0.41%
08 Sep
1,718.30
0.40%
05 Sep
1,715.00
0.19%
04 Sep
1,738.20
-0.85%
03 Sep
1,718.90
0.58%
02 Sep
1,729.80
-0.83%
01 Sep
1,721.40
0.24%
29 Aug
1,706.40
1.05%
28 Aug
1,712.10
-0.33%
26 Aug
1,754.60
-2.03%
25 Aug
1,759.00
-0.55%
22 Aug
1,721.10
1.56%
21 Aug
1,735.40
-0.43%
20 Aug
1,734.80
-0.39%
19 Aug
1,715.80
0.72%
18 Aug
1,730.60
-0.86%
J. B. Chemicals & Pharmaceuticals Limited Graph
J. B. Chemicals & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for J. B. Chemicals & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,699.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,700.10 | 1,717.10 | 1,545.39 - 1,888.81 |
| 1,734.10 | 1,387.28 - 2,080.92 | ||
| 1,751.10 | 1,225.77 - 2,276.43 | ||
| Bearish Scenario | 1,700.10 | 1,683.10 | 1,514.79 - 1,851.41 |
| 1,666.10 | 1,332.88 - 1,999.32 | ||
| 1,649.10 | 1,154.37 - 2,143.83 |
Overview of J. B. Chemicals & Pharmaceuticals Limited
ISIN
INE572A01036
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
299,427
Market Cap
266,197,540,400
Last Dividend
15.5
Official Website
IPO Date
2002-07-01
DCF Diff
-2,285.52
DCF
3,988
Financial Ratios Every Investor Needs
Stock Dividend of JBCHEPHARM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-07-30 | July 30, 25 | 7 | 7 | 2025-07-30 | 2025-08-13 | |
| 2025-02-07 | February 07, 25 | 8.5 | 8.5 | 2025-02-08 | 2025-02-21 | |
| 2024-08-14 | August 14, 24 | 6.75 | 6.75 | 2024-08-14 | 2024-09-20 | |
| 2024-02-16 | February 16, 24 | 5.5 | 5.5 | 2024-02-16 | 2024-03-07 | |
| 2023-08-17 | August 17, 23 | 4.625 | 9.25 | 2023-08-17 | 2023-09-23 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3,917.99 Cr | 1,316.55 Cr | 2,601.44 Cr | 0.6640 | 44.84 Cr | 0.00 Cr | 1,913.83 Cr | 659.58 Cr | 42.45 | 1,031.84 Cr | 0.1683 |
| 2024-03-31 | 3,447.67 Cr | 2,121.75 Cr | 1,325.92 Cr | 0.3846 | 30.56 Cr | 33.70 Cr | 754.16 Cr | 552.63 Cr | 35.66 | 933.48 Cr | 0.1603 |
| 2023-03-31 | 3,116.51 Cr | 1,184.80 Cr | 1,931.71 Cr | 0.6198 | 31.93 Cr | 547.04 Cr | 584.51 Cr | 409.84 Cr | 26.50 | 704.37 Cr | 0.1315 |
| 2022-03-31 | 2,424.24 Cr | 863.37 Cr | 1,560.87 Cr | 0.6439 | 29.11 Cr | 57.99 Cr | 473.90 Cr | 385.36 Cr | 24.93 | 581.53 Cr | 0.1590 |
| 2021-03-31 | 2,005.85 Cr | 717.44 Cr | 1,288.41 Cr | 0.6423 | 23.53 Cr | 7.88 Cr | 489.54 Cr | 447.96 Cr | 28.98 | 672.26 Cr | 0.2233 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 129.45 Cr | 4,273.78 Cr | 840.46 Cr | 3,433.3200 Cr | 27.89 Cr | -101.56 Cr | 528.95 Cr | 656.64 Cr | 0.00 Cr | 0.00 Cr | 27.98 Cr | 632.3300 Cr |
| 2024-03-31 | 88.22 Cr | 3,994.13 Cr | 1,070.80 Cr | 2,923.3300 Cr | 377.66 Cr | 289.44 Cr | 502.51 Cr | 634.88 Cr | 12.99 Cr | 1.70 Cr | 29.09 Cr | 868.2261 Cr |
| 2023-03-31 | 76.93 Cr | 3,553.87 Cr | 1,073.52 Cr | 2,480.3500 Cr | 572.45 Cr | 495.52 Cr | 430.49 Cr | 576.42 Cr | 118.25 Cr | 2.49 Cr | 28.09 Cr | 554.4500 Cr |
| 2022-03-31 | 56.54 Cr | 2,607.40 Cr | 468.79 Cr | 2,134.1230 Cr | 54.56 Cr | -1.99 Cr | 409.96 Cr | 566.82 Cr | 116.47 Cr | 3.17 Cr | 12.72 Cr | 383.7156 Cr |
| 2021-03-31 | 28.69 Cr | 2,238.12 Cr | 424.69 Cr | 1,809.7248 Cr | 44.99 Cr | 16.30 Cr | 347.45 Cr | 569.66 Cr | 108.56 Cr | 4.93 Cr | -651.88 Cr | 345.2737 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 902.4500 Cr | -295.8900 Cr | -579.6800 Cr | 804.8600 Cr | 26.8700 Cr | 115.0900 Cr | -97.5900 Cr | 659.5800 Cr | -343.9200 Cr | -237.0400 Cr | -26.4400 Cr |
| 2024-03-31 | 760.4757 Cr | -407.9074 Cr | -341.2720 Cr | 539.2447 Cr | 11.0507 Cr | 88.2151 Cr | -126.1128 Cr | 552.6278 Cr | -191.5957 Cr | -156.9875 Cr | -72.0300 Cr |
| 2023-03-31 | 625.6100 Cr | -961.7900 Cr | 356.5400 Cr | -139.3400 Cr | 20.3900 Cr | 76.9300 Cr | -764.9500 Cr | 555.2300 Cr | 523.1596 Cr | -127.5926 Cr | -20.5200 Cr |
| 2022-03-31 | 170.1345 Cr | 2.3199 Cr | -138.3851 Cr | -536.6547 Cr | 34.0703 Cr | 56.5441 Cr | -706.7892 Cr | 504.9020 Cr | -0.3273 Cr | -127.5628 Cr | -62.5143 Cr |
| 2021-03-31 | 314.7849 Cr | -230.6758 Cr | -87.4228 Cr | 267.0119 Cr | -3.2782 Cr | 22.4737 Cr | -47.7730 Cr | 596.8854 Cr | 0.3223 Cr | -73.2403 Cr | -70.0857 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1,093.94 Cr | 584.09 Cr | 509.85 Cr | 0.4661 | 258.17 Cr | 202.38 Cr | 12.97 | 315.42 Cr | 0.1850 |
| 2025-03-31 | 949.48 Cr | 321.64 Cr | 627.84 Cr | 0.6612 | 451.02 Cr | 145.69 Cr | 9.36 | 222.76 Cr | 0.1534 |
| 2024-12-31 | 963.49 Cr | 316.74 Cr | 646.75 Cr | 0.6713 | 212.57 Cr | 162.49 Cr | 10.46 | 262.51 Cr | 0.1686 |
| 2024-09-30 | 1,000.62 Cr | 550.87 Cr | 449.75 Cr | 0.4495 | 228.64 Cr | 174.57 Cr | 11.24 | 280.47 Cr | 0.1745 |
| 2024-06-30 | 1,004.40 Cr | 547.44 Cr | 456.96 Cr | 0.4550 | 239.59 Cr | 176.83 Cr | 11.39 | 286.26 Cr | 0.1761 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 129.45 Cr | 317.11 Cr | 446.56 Cr | 815.38 Cr | 528.95 Cr | 1,922.74 Cr | 656.64 Cr | 4,273.78 Cr | 840.46 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 416.86 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -3,212.23 Cr |
| 2024-09-30 | 97.46 Cr | 319.40 Cr | 416.86 Cr | 817.14 Cr | 543.67 Cr | 1,913.30 Cr | 641.67 Cr | 4,029.41 Cr | 817.18 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 459.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -2,923.33 Cr |
| 2024-03-31 | 95.54 Cr | 371.42 Cr | 460.19 Cr | 860.19 Cr | 502.51 Cr | 1,853.35 Cr | 634.88 Cr | 3,994.13 Cr | 1,070.80 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 145.69 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 162.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 174.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 176.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 126.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 88.22 Cr | 161.26 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2023-09-18 | September 18, 23 | 2:1 |
| 2005-04-05 | April 05, 05 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,616.60 | ₹3,878,676,048,000.00 | ₹1,878,887.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,026.50 | ₹1,599,848,928,500.00 | ₹487,570.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,566.20 | ₹1,206,962,559,000.00 | ₹139,352.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,316.70 | ₹1,095,964,560,653.00 | ₹1,042,670.00 |
| Mankind Pharma Limited | MANKIND | ₹2,579.60 | ₹1,064,750,578,074.00 | ₹181,489.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹1,044.75 | ₹1,051,258,792,500.00 | ₹559,507.00 |
| Lupin Limited | LUPIN | ₹2,043.40 | ₹933,333,167,000.00 | ₹1,611,273.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,448.00 | ₹651,390,120,000.00 | ₹120,660.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,094.40 | ₹635,629,708,800.00 | ₹793,814.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,132.50 | ₹601,793,632,500.00 | ₹615,366.00 |
| Laurus Labs Limited | LAURUSLABS | ₹896.05 | ₹483,710,191,250.00 | ₹1,298,692.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹980.40 | ₹375,068,694,643.00 | ₹176,773.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,314.80 | ₹333,570,019,200.00 | ₹237,352.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,579.10 | ₹322,222,437,600.00 | ₹58,260.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,699.90 | ₹266,197,540,400.00 | ₹56,240.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,518.00 | ₹246,651,927,918.00 | ₹287,476.00 |
| Piramal Enterprises Limited | PEL | ₹1,083.70 | ₹245,650,948,600.00 | ₹565,474.00 |
| Eris Lifesciences Limited | ERIS | ₹1,675.90 | ₹228,269,311,300.00 | ₹711,885.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,003.50 | ₹225,087,500,000.00 | ₹7,058.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹16,049.00 | ₹205,907,065,100.00 | ₹157,007.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹946.50 | ₹186,046,879,500.00 | ₹132,074.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,122.30 | ₹178,761,066,300.00 | ₹82,149.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,245.60 | ₹170,691,873,520.00 | ₹78,387.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹862.20 | ₹154,428,642,000.00 | ₹287,000.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹534.35 | ₹129,656,821,400.00 | ₹1,274,862.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,243.50 | ₹103,638,353,900.00 | ₹6,067.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹926.35 | ₹83,957,850,833.00 | ₹170,096.00 |
| Strides Pharma Science Limited | STAR | ₹909.75 | ₹83,854,113,825.00 | ₹182,119.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹827.60 | ₹80,931,748,840.00 | ₹90,322.00 |
| FDC Limited | FDC | ₹463.35 | ₹75,438,013,500.00 | ₹27,055.00 |
| Innova Captab Limited | INNOVACAP | ₹859.60 | ₹49,190,549,828.00 | ₹33,571.00 |
| Suven Life Sciences Limited | SUVEN | ₹224.63 | ₹48,978,481,767.00 | ₹179,307.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹509.65 | ₹46,515,755,500.00 | ₹129,437.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹143.10 | ₹46,439,098,200.00 | ₹131,426.00 |
| Sequent Scientific Limited | SEQUENT | ₹182.51 | ₹45,688,640,850.00 | ₹212,635.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,380.30 | ₹39,367,781,700.00 | ₹11,398.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹369.25 | ₹37,027,651,500.00 | ₹37,782.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹710.75 | ₹36,048,600,325.00 | ₹42,599.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹506.40 | ₹35,653,497,120.00 | ₹17,743.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹115.76 | ₹33,978,685,520.00 | ₹10,738,156.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹677.55 | ₹32,626,065,150.00 | ₹56,274.00 |
| Hikal Limited | HIKAL | ₹257.45 | ₹31,743,842,450.00 | ₹240,530.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹53.90 | ₹29,534,720,600.00 | ₹3,571,211.00 |
| Indoco Remedies Limited | INDOCO | ₹299.05 | ₹27,586,734,495.00 | ₹342,407.00 |
| Alembic Limited | ALEMBICLTD | ₹103.16 | ₹26,489,631,017.00 | ₹256,891.00 |
Key Executives
Executive Vice President of Operations of Daman
Mr. Parmeshwar B. Bang
Gender: male
Year Born: 1968
Vice President of Legal
Mr. Himanshu Ranvah
Gender: male
Year Born: 1985
Vice President of Finance & Accounts
Mr. Bhagwat Singh Deora
Gender: male
Year Born: 1982
Vice President of Information & Technology
Mr. Suresh Bhise
Gender: male
Year Born: 1966
Vice President of HR & Administration
Mr. Sridhar Bharadwaj
Gender: male
Year Born: 1967
Chief Financial Officer
Mr. Narayan Saraf
Gender: male
Year Born: 1980
Assistant Vice President Human Resource
Suresh Amin
Gender: Not Specified
Year Born:
President of Operations
Mr. Kunal Khanna
Gender: male
Year Born: 1980
President of Global Business
Mr. Pradeep Kumar Singh
Gender: male
Year Born: 1964
Chief Executive Officer & Whole-Time Director
Mr. Nikhil Ashokkumar Chopra
Gender: male
Year Born: 1973
FAQs about J. B. Chemicals & Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Nikhil Ashokkumar Chopra.
What is the current market price of the stock?
The current price is ₹1,699.90.
What is the 52-week price range?
The range is ₹1385.75-1984.
What is the market capitalization of the company?
The market capitalization is ₹26,619.75 crores.
What is the dividend yield?
The dividend yield is 0.91%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 38.72.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of J. B. Chemicals & Pharmaceuticals Limited (ISIN: INE572A01036) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹26,619.75 crores and an average daily volume of 299,427 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹15.5.